LASA SUPERGENERICS
Back to Cashflow Statement
|
LASA SUPERGENERICS Last 5 Year Net Cash Inflow / Outflow History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Cash Inflow / Outflow | ₹-0.19 Cr | ₹-10 Cr | ₹6.26 Cr | ₹1.27 Cr | ₹2.15 Cr |
What is the latest Net Cash Inflow / Outflow ratio of LASA SUPERGENERICS ?
Year | Net Cash Inflow / Outflow |
---|---|
Mar2024 | ₹-0.19 Cr |
Mar2023 | ₹-10 Cr |
Mar2022 | ₹6.26 Cr |
Mar2021 | ₹1.27 Cr |
Mar2020 | ₹2.15 Cr |
How is Net Cash Inflow / Outflow of LASA SUPERGENERICS Trending?
Years | Net Cash Inflow / Outflow | % Change | |
---|---|---|---|
Mar2024 | ₹-0.19 Cr | Negative | |
Mar2023 | ₹-10 Cr | Negative | |
Mar2022 | ₹6.26 Cr | 392.83 | |
Mar2021 | ₹1.27 Cr | -40.88 | |
Mar2020 | ₹2.15 Cr | - |
Compare Net Cash Inflow / Outflow of peers of LASA SUPERGENERICS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
LASA SUPERGENERICS | ₹129.3 Cr | -11.1% | -7% | -18.7% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹409,303.0 Cr | 1.4% | -4.1% | 32.1% | Stock Analytics | |
DIVIS LABORATORIES | ₹143,389.0 Cr | -4.2% | -5.1% | 59.6% | Stock Analytics | |
CIPLA | ₹114,645.0 Cr | -2.2% | -7.3% | 0.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹98,449.5 Cr | -7.1% | -13.8% | 8% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹91,587.4 Cr | -6.4% | -5.2% | 31.2% | Stock Analytics |
LASA SUPERGENERICS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
LASA SUPERGENERICS | -11.1% |
-7% |
-18.7% |
SENSEX | 0.1% |
-3.6% |
7.9% |
You may also like the below Video Courses